Simulations Plus Acquires Assets of Sage Informatics LLC

Division: Simulations Plus

SimulationsPlus, Inc. (AMEX: SLP), today announced that it has acquired the assets of Sage Informatics LLC of Santa Fe, New Mexico, a chemistry software company providing research tools to the pharmaceutical and biotechnology industries. The president of Sage Informatics, David Miller, Ph.D., will join the Company’s Life Sciences team as Senior Scientist and Product Manager for the ChemTK™ product line effective October 1, 2005. Financial details were not disclosed.

Walt Woltosz, chairman and chief executive officer of Simulations Plus, said: “We are excited to announce this strategic acquisition. Sage Informatics has created an outstanding line of products in its ChemTK™, ChemTK Lite™, and ChemTKX™ series (www.sageinformatics.com). These products provide valuable information and guidance to computational chemists and medicinal chemists in the early drug discovery process. The software programs and the technologies behind them will not only add complementary new products to our current offerings, but will also provide a technology base for expanding our offerings in the future.”

Ron Creeley, vice president of marketing and sales, commented: “This acquisition simultaneously broadens our product line with innovative new products and includes a number of new customers, both in the form of new companies as well as new departments within our existing customers. These new contacts are expected to provide us with further opportunities to introduce our products, especially ADMET Predictor™ and ADMET Modeler™.”

David Miller, Ph.D., President of Sage Informatics LLC, added: “Simulations Plus provides the ideal home for the ChemTK series of products, and I am looking forward to working with the very talented team there. I expect that with the additional support of the Simulations Plus marketing and sales and life sciences teams, the technologies we have developed in the ChemTK product line will see even greater success in the marketplace.”